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Abstract 
Treatment efficacy is largely determined by statistical significance testing, and clinical 
significance testing is often used to quantify or qualify the efficacy of a treatment at the 
individual or group level. This study applies the equivalence based clinical significance model 
proposed by Kendall, Marrs-Garcia, Nath and Sheldrick (1999), and a revised model proposed 
by Cribbie and Arpin-Cribbie (2009), to the assessment of treatments for depression. Using 
several studies that investigated treatments for depression, we tested whether the post-treatment 
means were equivalent to the means for a similar normal comparison group. All of the studies 
had significant improvement from pretest to posttest, although for many of the studies the treated 
group was not equivalent to a normal comparison group at posttest. Further, there are important 
differences between the conclusions drawn from the Kendall et al. and Cribbie and Arpin-
Cribbie methods for assessing equivalence based clinical significance. 
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Equivalence-based Measures of Clinical Significance: 
Assessing Treatments for Depression 
 
 Psychotherapy research has uncovered many treatments to mitigate the symptoms of, or 
help individuals cope with, various ailments. Traditionally, tests of statistical significance act as 
the hallmark for efficacy, although it is important to highlight that qualitative outcomes also play 
an important role in understanding the efficacy of an intervention. For example, the patient’s 
subjective evaluation of the intervention effects, or more specifically the therapeutic alliance 
(Warren, 2001) and personal significance (Sweeney, MacAuley & Pereira Gray, 1998) of the 
intervention are important factors in evaluating an intervention. From a quantitative standpoint, a 
“statistically significant” difference between the treatment and control groups in response to an 
intervention leads readers to infer that the intervention does indeed ameliorate clients’ 
psychological well-being. However, is this sort of assessment sufficient in branding a treatment 
as “effective”? The treatment may have yielded a considerable improvement in the condition of 
the client, but overall, was the treatment “clinically significant”? 
 Jacobson and Truax (1991) argue that tests of “statistical significance” neither indicate 
the variability of response to the treatment in question within the sample, nor translate to the 
clinical efficacy of the treatment. Thompson (2002) argues that “statistical significance” alone is 
not enough to assess the efficacy of a particular treatment, and instead favors using effect sizes, a 
concept he deems “practical significance”. Thompson also discusses “clinical significance”, a 
concept pursued by researchers for several years. Researchers interested in assessing the efficacy 
of treatments have used the term “clinical significance” to indicate whether or not these 
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treatments are capable of helping patients return to a state of normalcy. For instance, Ogles, 
Lunnen and Bonesteel (2001) dichotomize evaluation into “subjective” and “social” components, 
the former pertaining to the qualitative change in the individual as observed by others, the latter 
to comparisons to nondeviant peers. An intervention is often described as being clinically 
significant when the behavior of the clients is indistinguishable from a normal reference group, 
though the researcher must determine what constitutes a normative level and when the use of 
such a reference group is appropriate. Finding an appropriate normal reference group can often 
be difficult, especially when trying to match the clinical and normal comparison groups on 
important individual characteristics (e.g., age, cultural background). 
 
Assessing Clinical Significance 
 Several models have been proposed to quantitatively assess “clinical significance” at the 
individual level. Jacobson and Truax (1991) define clinically significant change as that which 
brings the client’s level of functioning closer to the “functional” population, and cite three 
potential cut-off points for clinically significant change: either the post-treatment score lies 
within two standard deviations of the “functional” mean, at least two standard deviations away 
from the “dysfunctional” mean, or beyond the halfway point between these two values (Jacobson 
& Truax, 1991; Ogles et al., 2001). Jacobson and Truax also  present a “reliable change index” 
(RCI) to account for overlap in functional and dysfunctional distributions (Jacobson & Truax, 
1991; Jacobson, Follette & Revenstorf, 1984); in other words, the RCI is designed to ensure that 
a post-test score that crosses the “functional” cut-off point is indeed statistically reliable 
(Jacobson & Truax, 1991). Bauer, Lambert & Nielsen (2004) compared five measures of 
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individual level clinical significance and recommended the Jacobson and Truax method for its 
ease of calculation and compatibility with multiple measures. An important characteristic of 
these methods is that they assess clinical significance at the individual level. However, the 
methods that will be discussed in this paper take a different approach to quantifying clinical 
significance, specifically addressing clinical significance at the group level. The assessment of 
group level clinical significance is performed through the use of equivalence testing methods, 
which are introduced in the following sections. 
 
Introduction to Equivalence Testing 
 The goal of mean equivalence testing is to determine if two (or more) group means are 
comparable (equivalent), within an appropriate interval. Schuirmann (1987) developed a two 
one-sided testing approach for determining if two group means are equivalent, the hypotheses for 
which are as follows: 
H01: μ1 – μ2 ≤ θ1 ; H02: μ1 –μ2 ≥ θ2 
H11: μ1 – μ2 > θ1 ; H02: μ1 – μ2 < θ2 
where μ1 and μ2 refer to the group means and [θ1, θ2] the lower and upper limits of the 
“equivalence interval” (which are usually symmetrical, i.e., θ1 = -θ2). Contrary to conventional 
statistical tests, the composite null hypothesis denotes a difference, while the composite alternate 
hypothesis relates to equivalence. Ho1 is rejected if t1 ≥
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and Ho2 is rejected if t2 ≤ -t α,df where: 
 
 . 
    
 
M1 and M2 are the group means, n1 and n2 are the group sample sizes, s1 and s2 are the group 
standard deviations and tα,df is the upper-tailed α-level t critical value with n1 + n2 - 2 degrees of 
freedom (df). It is important to note that in order to declare the means equivalent both null 
hypotheses must be rejected; in other words, rejection of HO1 implies that the difference in the 
means is greater than θ1 and rejection of HO2 implies that the difference in the means is less than 
θ2. Rogers, Howard and Vessey (1993) define an equivalence interval as a difference in the 
means that is “important enough to make the groups non-equivalent” (p. 554). From the opposite 
perspective, it would be the largest difference that is meaningless within the framework of the 
research. 
 
Clinical Significance through Equivalence Testing  
 Kendall, Marrs-Garcia, Nath and Sheldrick (1999) outlined a ‘normative comparisons’ 
approach which involves evaluating the equivalence of a treated population and a representative 
normative population. These normative comparisons can provide insight into the efficacy of a 
clinical intervention. In other words, if the goal of a treatment is to return the participants to a 
state of normal functioning, then a logical way to evaluate the treatment is to determine if the 
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mean of the treated population is equivalent to the mean of the normal population. Kendall et al. 
are in accord with Rogers, Howard and Vessey (1993), as they believe that determining an 
equivalence interval must be tailored to the application in question, though they suggest, as a 
heuristic, a range of ±1.0 standard deviations (SDs) from the normative mean (i.e., θ1 = (-1) 
SDnormal and θ2 = (1) SDnormal. Kendall et al. propose testing for both the equivalence of the means 
and for differences in the means.  
 There are two approaches by which normative data can be obtained, the researcher can 
utilize existing published data or the researcher can collect her or his own normative sample 
(Kendall et al., 1999). The latter is often a preferred option, as the treated group will often not be 
comparable to the normative group on important dimensions. Kendall and Sheldrick (2000) cite 
several advantages to collecting representative normative data: (1) the process can be tailored to 
the target research question; (2) normative data can be obtained for all required measures, rather 
than using published data in a piecemeal manner; (3) one can control for test-sensitization and 
reactivity; and (4) the normative data be matched to the clinical data on important demographic 
characteristics. However, despite its numerous advantages, collecting data is quite expensive, 
requiring much time and money, thereby prompting some investigators to favor using published 
normative data as a basis for normative comparisons. 
 
Advancing Clinical Significance through Equivalence Testing.  
 Recently, Cribbie and Arpin-Cribbie (2009) expanded upon the normative comparisons 
approach proposed by Kendall et al. (1999). The Cribbie and Arpin-Cribbie method involves two 
(hierarchical) steps: First, the pre-test mean is compared to the normative mean using a 
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difference-based two independent samples t test with a non-pooled standard error (i.e., a test that 
does not assume that the variances of the groups are equal). If the pre-test and normative means 
differ, then the second step is to evaluate whether the post-test and normative group means are 
equivalent (if the pre-test and normative means do not differ, then no further testing is conducted 
because the treatment group and normative group do not differ before the intervention).  
 With regard to a test statistic for evaluating equivalence, it is important that the test 
statistic be robust to situations in which the sample sizes and variances of the groups differ 
because often the normative group is larger and less variable than the clinical group (which can 
substantially inflate the Type I error rate of the Schuirmann test, see Gruman, Cribbie & Arpin-
Cribbie, 2007). Kendall et al. (1999) recognized the problem of variance heterogeneity in 
equivalence testing, but failed to account for it in their model (i.e., their method utilizes the 
original Schuirmann procedure). To more formally illustrate this issue, imagine a group of 
individuals treated for major depression. Many will likely respond satisfactorily to an established 
intervention, but some will experience little or no change (or even deterioration) and some will 
improve substantially. This will in most cases lead to a post-test distribution with greater 
variability than the distribution of depression scores in the normal population. In other words, 
though the distribution of scores in the general population will undoubtedly include outliers, 
typically the distribution will be narrower than that of the treated population.  
 To address this problem, Cribbie and Arpin-Cribbie integrate Welch’s (1938) 
heteroscedastic standard error and degrees of freedom into their model (Schuirmann-Welch test), 
thus accounting for the sometimes vast differences between sample sizes and variances of the 
treated and normal samples. Cribbie and Arpin-Cribbie assess equivalence using the 
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Schuirmann-Welch method at intervals of 0.5, 1.0 and 1.5 SDs (of the normative group). 
Assessing equivalence at multiple levels affords the researcher the opportunity to determine the 
degree to which a declaration of equivalence is made. Declarations of equivalence at the .5, 1.0 
and 1.5 SD levels were labeled  ‘definitive equivalence’, ‘probable equivalence’, and ‘potential 
equivalence’, respectively, by Cribbie and Arpin-Cribbie. Cribbie and Arpin-Cribbie also 
recommend against using infinity as a limit (which was used by Kendall & Sheldrick, 2000, in 
conducting normative comparisons) for the researcher then disregards instances in which the 
treatment group outperforms the normal comparison group, which might be an interesting event 
in and of itself. Oddly, Bauer et al. (2004) make no mention of Kendall et al. (1999) in their 
review of methods for evaluating clinical significance testing, although it is quite conceivable to 
presume that these models were simply overlooked by the researchers when assessing 
methodologies. However, it is also quite common for one to be reluctant to utilize new 
advancements in assessment, much like with any new discovery in any field, especially if the 
established model is perceived as valid and reliable. 
 
Application of Equivalence-Based Measures of Clinical Significance  
 Sheldrick, Kendall & Heimberg (2001) employed the Kendall et al. (1999) methodology 
when testing treatments for conduct disorder. Their study examined three treatments across 14 
studies, comparing treatment scores to age-appropriate normative data on the Child Behavior 
Checklist (Achenbach & Edelbrock, 1983) and the Eyberg Child Behavior Inventory (Eyberg & 
Ross, 1978). A total of 50 sets of pre- and post-treatment scores were examined across 23 
treatment conditions, and out of these, all but three exhibited clinically significant change as 
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indicated by the Jacobson and Truax (1991) “reliable change index” (adapted for group 
comparisons). Sixteen out of the 50 post-treatment scores were deemed “equivalent” (significant 
equivalence test and nonsignificant difference test), 32 “different” (non-significant equivalence 
test and significant difference test) and two “equivocal” (non-significant equivalence test and 
non-significant difference test) 
 
The Current Study 
 The purpose of this study is to evaluate the utility of the Kendall et al. (1999) and Cribbie 
and Arpin-Cribbie (2009) equivalence-based methods of clinical significance by applying these 
methods to a sample of studies employing interventions for depression. Depression was selected 
because it is a common ailment affecting a vast number of people, and a large number of studies 
have been published assessing treatments; for example, cognitive behavioural therapy 
(Bodenmann et al., 2008; MacKinnon, Griffiths & Christensen, 2008; Horowitz, Garber, Ciesla, 
Young & Mufson, 2007; Kingston, Dooley, Bates, Lawlor & Malone, 2007), problem-solving 
therapy (Eskin, Ertekin & Demir, 2008) and emotion-focused therapy (Ellison, Greenberg, 
Goldman & Angus, 2009). This study compares the post-treatment scores of clinical trials to 
published normative data on corresponding measures. The aim of this study is three-fold: (1) 
evaluate the clinical significance of interventions using equivalence testing approaches, (2) 
compare the conclusions derived from the equivalence based tests of clinical significance to the 
traditional tests of significance, and (3) compare the results for the Kendall et al. and Cribbie and 
Arpin-Cribbie equivalence-based measures of clinical significance. 
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Method 
Selection of Studies  
 We applied various search criteria in the PsycINFO and Google Scholar databases, 
including combinations of “depression”, “treatment”, “intervention” and “randomized control 
trial”, and retrieved studies accordingly. The studies utilized numerous outcome variables, 
including two versions of the Beck Depression Inventory, BDI (Beck, Ward, Mendelson, Mock 
& Erbaugh, 1961) and BDI-II (Beck, Steer & Brown, 1996), the Center for Epidemiological 
Studies Depression scale (CES-D; Radloff, 1977), and the Hamilton Rating Scale for Depression 
(HRSD; Hamilton, 1960) and its derivatives. 
 Studies must have reported post-test means, standard deviations and sample sizes to be 
utilized in this study. As equivalence testing compares treated to normal groups, waiting list and 
other control groups were omitted. All but one study included pre-test means and standard 
deviations, which were used, with the post-test data, to calculate Cohen’s standardized effect size 
(d) and whether there was a statistically significant change from pre-test to post-test. Although a 
few studies included measures of effect size, in many cases it was difficult to determine how it 
was computed (e.g., just for the pre-post change or for the pre-post change relative to a control 
group) and many studies did not include an effect size. Therefore, Cohen’s d was calculated for 
each study assuming a correlation between pre-test and post-test of r = .5. Follow-up data 
provide insight into persistence and relapse rates, but were not considered necessary for this 
investigation. Furthermore, with respect to symptoms, there must exist the potential for clients to 
return to a state of normalcy (see Cribbie & Arpin-Cribbie, 2009). For example, one might not 
anticipate a group of individuals to achieve a state of normal functioning on, say, a depression 
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scale, if the group also suffers from a comorbid disorder, such as avoidant personality disorder, 
that limits the effectiveness of an intervention (e.g., Papakostas et al., 2003). 
 
Normative Comparisons  
 In order to determine clinical significance, treatment groups must be compared to a 
sample representative of the “normal” population. For a most appropriate comparison, it is 
advised that representative normative data be collected by the researchers (Kendall & Sheldrick, 
2000), or that normative data that matches important characteristics of the sample (e.g., age, 
gender, socioeconomic status) be identified in the literature. It would be impractical for us to 
attempt to collect representative data to match each study we identified, and thus we used 
existing published normative data for our comparisons (in each case trying to find normative data 
that closely matched the characteristics of the populations used in the intervention studies). 
 
Statistical Analysis 
 We modeled both the Kendall et al. (1999) and the Cribbie and Arpin-Cribbie (2009) 
procedures with the R statistical software application (R Foundation for Statistical Computing, 
2008). For Kendall et al. (1999), the equivalence interval was set at plus or minus 1.0 SD of the 
normative sample. For Cribbie and Arpin-Cribbie (2009), three equivalence intervals were 
utilized, specifically 0.5, 1.0 and 1.5 times the SD of the normative sample. For each of the 
Kendall et al. and Cribbie and Arpin-Cribbie methods, the treated and normative samples are 
deemed equivalent if the null hypothesis for both t1 and t2 can be rejected.  
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Results 
 The references for published normative data used in this investigation are presented in 
Table 1. Appropriate normative data could only be found for the BDI, BDI-II, CES-D, and 17-
item version of the HRSD, and therefore other versions of the HRSD were excluded. An 
important finding of this study was that it is very difficult to find representative normative data 
for many of the depression scales. Specifically, although we believe we have found acceptable 
normative data for each of the depression studies we collected, the lack of normative data for 
many of these scales limited how precise we could be in matching the characteristics of the 
treated and normative samples. For example, MacKinnon et al. (2008) conducted their study of 
Internet cognitive-behavioural therapy for depression using the CES-D with adults from Great 
Britain, yet their results were compared with a normative sample of CES-D scores consisting of 
adults in the Netherlands (Bouma, Ranchor, Sanderman, & Van Sonderen, 1995) because more 
representative data was not available. Future studies will hopefully improve on the availability of 
representative normative data. 
 Fifteen studies were selected that investigated 22 treatments for depression. Some studies 
included multiple samples, multiple interventions and/or multiple outcome variables. In order to 
limit the number of studies, and avoid non-independence issues, only one sample, intervention 
and/or outcome was randomly selected from each study. 
 Table 2 summarizes pre- and post-test data for each trial, sorted by clinical measure. 
Specifically, these tables highlight the treatments investigated in each trial, the means, standard 
deviations and sample sizes of each group, whether there was a statistically significant change 
from pre-test to post-test, and the effect size for the pre-test to post-test change (Cohen’s d). All 
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of the interventions had significant change from pre-test to post-test and had Cohen’s d values 
greater than .5. 
 Table 3 summarizes findings of “clinical significance” as ascertained from the Kendall 
and Cribbie and Arpin-Cribbie methods, sorted by clinical measure. The first step of the Cribbie 
and Arpin-Cribbie method, comparing the pre-test and normative means, had to be skipped for 
one study (Cuijpers, Smit, Woordouw, & Kramer, 2005) because pre-test data were not provided. 
For the remaining studies the pre-test means all differed significantly from the normative means.  
 Of the 15 treated groups we investigated, 11 exhibited statistically significant differences 
and the treated samples were found to be equivalent to the normal comparison group using the 
Kendall method. On the other hand, only five exhibited the same result using the Cribbie and 
Arpin-Cribbie method at the 1.0 SD interval, and 10 at the 1.5 SD interval. Therefore, four 
groups exhibited statistically significant differences, but the treated group was not equivalent to 
the normal comparison group according to the Kendall method, whereas 10 exhibited the same 
result using the Cribbie and Arpin-Cribbie method at the 1.0-SD interval, and 5 at the 1.5 SD 
interval.  
 With respect to the Cribbie and Arpin-Cribbie method, it is clear that declaring the 
treated group equivalent to the normal comparison group with an equivalence interval of half the 
SD of the normal comparison group (0.5 SD) is very difficult, relative to declarations of 
equivalence at the 1.0 and 1.5-SD intervals. In fact, only one study (Ellison et al., 2009) featured 
a treatment (emotion-focused therapy) that was clinically significant at the 0.5 SD level. 
 Table 4 compares the frequencies of equivalence decisions for both the Kendall and 
Cribbie and Arpin-Cribbie methods at an equivalence interval of 1.0 SD. Most importantly, there 
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were six instances in which the Kendall method declared the treated participants equivalent to 
the normal comparison group and the Cribbie and Arpin-Cribbie method did not. The only 
difference between the methods is that the Kendall et al. procedure uses the traditional standard 
error and degrees of freedom from the two independent samples t-test, whereas the Cribbie and 
Arpin-Cribbie model uses a non-pooled standard error and adjusted degrees of freedom, as 
suggested by Welch (1938), that are robust to violations of the variance homogeneity 
assumption. Therefore, only the results due to the Welch-based statistics can be considered 
accurate. 
 
Discussion 
 Clinical significance testing provides a necessary complement to traditional statistical 
significance testing. A statistically significant result tells the reader that the treatment was 
effective in reducing the potency of symptoms (often relative to a control group), but does not 
imply that the client has returned to a state of “normal” functioning, which is the primary goal of 
most intervention studies for depression. In the current study, we found that, regardless of the 
statistical significance of the change from pre- to post-test or the associated effect size, the 
equivalence-based measures of clinical significance added important information about the 
effectiveness of the intervention. In short, an intervention can have a statistically significant 
effect on clients, i.e., it can significantly mitigate one’s symptoms, but not necessarily result in a 
return to a “normal” state, as compared with normative scores on a given clinical measure. This 
finding has a particularly important implication pertaining to the administration of an 
intervention. A given intervention may render a statistically significant difference from pre- to 
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post-test for the treatment group, but if the intervention does not return the group to a state of 
normal functioning, this may highlight potential issues with the treatment (e.g., not enough time 
for complete results to be observed). In the current study, we found that a variety of treatments 
were effective in returning clients to a state of normal functioning, including mindfulness-based 
CBT, emotion-focused therapy, and various online therapies. 
Traditional methods that examine clinical significance at the individual level (e.g., 
Jacobson & Truax, 1991) are beneficial when assessing the efficacy of an intervention for a 
particular individual, or for knowing the proportion of individuals that improved, deteriorated, 
etc. However, testing for clinical significance at the group level (i.e., testing for equivalence of 
the treatment group and a normative sample) better assesses overall treatment efficacy. More 
specifically, one can assess clinical significance by examining the performance of each 
individual in a treatment group and noting for whom the particular intervention was effective, 
but when assessing the effectiveness of the intervention itself, a test of the equivalence of the 
treated group and an appropriate normal comparison group can be very effective. However, it is 
important to mention that this method is only appropriate when the goal of the intervention is to 
return clients to a state of normal functioning. 
 The results of this study illustrate the importance of two important factors in equivalence-
based clinical significance testing: (1) accounting for variance heterogeneity; and (2) utilizing 
multiple equivalence intervals. First, the Kendall et al. model incorporates the traditional 
standard error and degrees of freedom from the sampling distribution of the difference between 
two means; i.e. it utilizes the original Schuirmann (1987) test of equivalence. When comparing a 
group treated with an intervention to a normal comparison group, often the normative sample 
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will both be much larger in size and have smaller variability than the treated sample. This 
combination of a large sample size with a small amount of variability for the normative sample 
(and hence a small sample size with a large amount of variability for the treated sample) means 
that the standard error for the t tests used in the Kendall et al. (1999) method will be extremely 
underestimated. In other words, the smaller variability of the normal comparison group gets 
weighted much higher than the larger variability of the treated group when computing the pooled 
variance term (and hence the pooled standard error). Thus, the Kendall et al. method will have an 
inflated Type I error rate; i.e. this method will often declare treated and normative comparison 
populations equivalent to a normal comparison group when, in fact, these populations are not 
equivalent to this group (see Gruman et al., 2007). Another important consequence of the use of 
non-pooled standard error by the Cribbie and Arpin-Cribbie (2009) method is that this test has 
been shown to more robust to moderate violations of normality than tests that adopt a pooled 
standard error (Algina, Oshima, & Lin, 2004). However, if the non-normality is more extreme, 
robust estimators (e.g., trimmed mean) may be necessary (Wilcox, 1994). When comparing the 
Kendall et al. and Cribbie and Arpin-Cribbie (2009) methods at an equivalence interval of 1.0 
standard deviation, in all cases in which the results did not match, the former returned an 
“equivalent” result while the latter returned a “not equivalent” result. It is expected that the 
majority of these equivalence decisions for the Kendall method are Type I errors (although 
obviously there is no way to verify this). Therefore, when using equivalence-based testing for 
clinical significance, if the homogeneity of variance assumption is violated, the validity of the 
results of the Kendall approach must be treated with caution.  
 Using multiple equivalence levels also adds a measure of confidence when determining 
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whether or not a treated group is indeed equivalent to the normal group. For example, if a treated 
group falls within 0.5 standard deviations of the normative mean, we can be confident that the 
two groups are equivalent; however, if the treated group falls within 1.5 standard deviations of 
the normative mean, readers should not have as much confidence in the result. 
 Another very important finding of this study is the extreme paucity of normative/referent 
data for the outcomes investigated. This was a very surprising finding given that we were 
investigating very popular depression scales (e.g., BDI). The lack of normative data for these, 
and likely many other, psychological scales is a significant hindrance to researchers conducting 
normative comparisons (if they have not collected separate normative data). More specifically, 
researchers will often be interested in matching their treated and normative samples on many 
different characteristics, and currently this will be very difficult to do given the lack of normative 
data available in the literature. It is hoped that future studies will collect normative data from a 
wide variety of populations. 
 There are a couple of limitations to the methodology of the current study. First, although 
we have tried to obtain a large sample of intervention studies for depression, this is obviously not 
an exhaustive list. Thus, it is unclear how the results (effect sizes, traditional statistical tests, 
normative comparisons) of the studies not selected for investigation would compare to those 
selected. Second, the effect sizes (Cohen’s d) utilized in this study for the pretest to posttest 
change were calculated under the assumption of a .5 correlation between pretest and posttest, 
because in most cases the standard error of the difference was not provided, or it was unclear 
how the effect size that was provided was calculated. It is possible that the true effect sizes 
deviated slightly from the calculated values.  
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 To summarize, this study examined interventions for depression and the results highlight 
that several therapeutic interventions are effective at not only improving the subject’s well being, 
but also returning the subjects depression levels to those similar to that of a normal comparison 
group. In the future, we recommend that equivalence-based normative comparisons be utilized 
whenever an intervention for a psychological malady is undertaken and the goal is to return the 
members of the clinical group to a state of normal functioning. An R (The R Foundation for 
Statistical Computing, 2008) function for conducting the normative comparison tests discussed 
in this article is available at http://www.psych.yorku.ca/cribbie. 
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Table 1 
Published normative data used in the normative comparison analyses. 
 
Scale Reference M SD N Characteristics 
BDI De Berardis et al. 
(2007) 
9.0 8.4 288 Undergraduate women in Italy 
Seggar et al. 
(2002) 
7.22 6.33 28,905 Community sample 
Teri (1982) 8.47 8.03 568 Adolescents in high school 
Joseph et al. 
(1996) 
7.33 6.54 194 Undergraduate students in N. 
Ireland 
BDI-II Uebelacker et al. 
(2003) 
7.4* 6.6* 127 Married adults in U.S.A. 
CES-D Joseph et al. 
(1996) 
14.23 10.87 194 Undergraduate students in N. 
Ireland 
Murrell et al. 
(1983) 
9.36 9.2 936 Persons age 55 and over in 
Kentucky 
Bouma et al. 
(1995) 
9.7 8.6 2768 Citizens of the Netherlands 
HRSD-
17 
Grundy et al. 
(1996) 
6.25 4.24 203 General population in U.S.A. 
Note: * = average of female and male means 
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Table 2 
Statistical data from the target studies. 
 
Reference Intervention Pre-test Post-test Pre-
Post 
Change 
p<.05 
Cohen’s 
d M SD N M SD N 
BDI 
Kingston et al. 
(2007) 
Mindfulness-based 
CBT 
30.3 7.6 6 12.3 9.7 6 Yes 2.23 
Eskin et al. (2008) Problem-solving 26.7 9.4 27 10.7 10.4 27 Yes 1.64 
Ellison et al. (2009) Emotion-focused 26.3 6.9 27 6.7 5.8 27 Yes 3.11 
Straumann et al. 
(2006) 
Cognitive Therapy 24.6 6.2 18 10.7 7.1 18 Yes 2.13 
BDI-II 
Friedman et al. 
(2005) 
GIFT program 25.4 7.1 13 9.9 8.7 13 Yes 2.01 
Learmonth et al. 
(2008) 
Beat the Blues 24.2 11.1 244 15.8 11.0 244 Yes 0.76 
Spek et al. (2007) Internet-based CBT 19.1 7.2 102 11.9 8.0 102 Yes 0.95 
Karavidas et al. 
(2007) 
HRV biofeedback 26.1 3.4 11 15.8 2.4 8 Yes 3.64 
CES-D 
MacKinnon et al. 
(2008) 
Internet-based CBT 21.8 10.5 182 15.9 9.8 136 Yes 0.58 
Gerrits et al. (2007) Online interaction 32.6 9.3 50 18.7 9.4 50 Yes 1.5 
Haringsma et al. 
(2006) 
Coping class 31.9 8.2 21 21.5 9.6 21 Yes 1.19 
Cuijpers et al. 
(2005) 
Coping class Not 
reported 
187 17.0 9.9 128 NA 0.84* 
HRSD-17 
Bodenmann et al. 
(2003) 
Interpersonal 
psychotherapy 
13.9 3.3 20 9.3 5.8 18 Yes 0.94 
Dimidjian et al. 
(2006) 
Cognitive therapy 22.7 
 
2.6 
 
25 
 
10.3 
 
7.6 
 
18 
 
Yes 1.91 
Hellerstein et al. 
(2008) 
Adjunctive aripiprazole 21.6 4.3 14 12.6 7.5 14 Yes 1.43 
Note: CBT = Cognitive Behavioral Therapy; HRV = Heart Rate Variability; * = value reported in the paper. 
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Table 3 
Results for the Kendall et al. and Cribbie & Arpin-Cribbie normative comparisons.  
 
Reference Intervention Normative 
Reference 
Kendall 
1.0 SD 
Cribbie & Arpin-Cribbie 
0.5 SD 1.0 SD 1.5 SD 
BDI 
Kingston et al. 
(2007) 
Mindfulness-
based CBT 
De Berardis et al. 
(2007) 
E N/E N/E E 
Eskin et al. 
(2008) 
Problem-solving  Teri (1982) E N/E E E 
Ellison et al. 
(2009) 
Emotion-focused Seggar et al (2002) E E E E 
Straumann et 
al. (2006) 
Cogntive 
Therapy 
Seggar et al (2002) E N/E N/E E 
BDI-II 
Friedman et al. 
(2005) 
GIFT program Uebelacker et al. 
(2003) 
E N/E N/E E 
Learmonth et 
al. (2008) 
Beat the Blues Uebelacker et al. 
(2003) 
N/E N/E N/E N/E 
Spek et al. 
(2007) 
Internet-based 
CBT 
Uebelacker et al. 
(2003) 
E N/E E E 
Karavidas et 
al. (2007) 
HRV 
biofeedback 
Uebelacker et al. 
(2003) 
N/E N/E N/E N/E 
CES-D 
MacKinnon et 
al. (2008) 
Internet-based 
CBT 
Bouma et al. (1995) E N/E E E 
Gerrits et al. 
(2007) 
Online 
interaction 
Joseph et al. (1996) E N/E E E 
Haringsma et 
al. (2006) 
Coping class Murrell et al. 
(1983) 
N/E N/E N/E N/E 
Cuijpers et al. 
(2005) 
Coping class  Bouma et al. (1995) E N/E N/E E 
HRSD-17 
Bodenmann et 
al. (2003) 
Interpersonal 
psychotherapy 
Grundy et al. 
(1996) 
E N/E N/E E 
Dimidjian et 
al. (2006) 
Cognitive 
therapy 
Uebelacker et al. 
(2003) 
E N/E N/E N/E 
Hellerstein et 
al. (2008) 
Adjunctive 
aripiprazole 
Seggar et al. (2002) N/E N/E N/E N/E 
Note: E = treated and normal comparison groups equivalent, N/E = treated and normal comparison groups 
not equivalent; CBT = Cognitive Behavioral Therapy; HRV = Heart Rate Variability. 
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Table 4 
Normative comparison outcomes for the Kendall et al. and Cribbie & Arpin-Cribbie methods at 
an equivalence interval of 1 SD. 
 
 Cribbie & Arpin-Cribbie 
Equivalent Not Equivalent 
Kendall et al. 
Equivalent 5 6 
Not Equivalent 0 4 
 
